GP78-2 Inhibitors
GP78-2 inhibitors belong to a specific chemical class of compounds that have gained significant attention in the field of molecular biology and cellular regulation. These inhibitors are designed to target the GP78-2 protein, which is a crucial component of the endoplasmic reticulum-associated protein degradation (ERAD) pathway. The ERAD pathway plays a pivotal role in maintaining cellular homeostasis by identifying and eliminating misfolded or unwanted proteins from the endoplasmic reticulum (ER), preventing their accumulation and potential cellular toxicity.
The GP78-2 protein serves as an E3 ubiquitin ligase and is responsible for the ubiquitination and subsequent degradation of specific substrates within the ERAD pathway. GP78-2 inhibitors are designed to disrupt the activity of this protein, ultimately affecting the regulation of protein degradation within the ER. By inhibiting GP78-2, these compounds can modulate the ERAD pathway's efficiency, potentially leading to the accumulation of misfolded or unstable proteins. Researchers have been exploring GP78-2 inhibitors as valuable tools for understanding the intricacies of protein quality control and degradation within the ER, shedding light on the underlying mechanisms of protein folding and cellular stress responses. These inhibitors hold promise in unraveling the complex network of molecular interactions within the ERAD pathway, advancing our knowledge of cellular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A steroidal metabolite that acts as a potent inhibitor of phosphoinositide 3-kinases (PI3K), which could downregulate signaling pathways involving phosphorylation events potentially regulated by GP78-2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A morpholine derivative that also inhibits PI3K, potentially altering downstream effects of pathways where GP78-2 might have a role. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A hydroxamic acid that inhibits histone deacetylases (HDACs), altering chromatin structure and gene expression, potentially affecting GP78-2 expression or function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2, which is involved in the MAPK/ERK pathway, potentially altering signaling events that GP78-2 may influence. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A pyridinyl imidazole that selectively inhibits p38 MAPK, potentially modulating pathways where GP78-2 is a regulatory component. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
A macrolide compound that binds to FKBP12 and inhibits mTOR, which could affect signaling pathways that involve GP78-2 indirectly. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
An alkaloid that inhibits a wide range of protein kinases, potentially affecting the activity of GP78-2 through modulation of phosphorylation states. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A synthetic compound that inhibits MEK, which might affect signaling pathways involving GP78-2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An anthrapyrazolone inhibitor of JNK, possibly altering signaling cascades that GP78-2 is a part of. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A selective inhibitor of Src family tyrosine kinases, potentially impacting signaling pathways where GP78-2 is involved. | ||||||